Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€3.82
09.01.23
-
09.01.24
106.03%
17.01.23

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
Bed Bath & Beyond Inc.

Start price
Target price
Perf. (%)
€7.75
20.09.22
€3.00
20.09.23
-52.24%
11.01.23

Revenue growth >5% per year expected
Higher EBIT margin than peer group
Very low/no dividend yield expected
very negative Cash Flow expected
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€21.36
13.10.22
€20.00
13.10.23
-48.44%
11.01.23

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
buy
Bed Bath & Beyond Inc.

Start price
Target price
Perf. (%)
€1.90
10.01.23
€3.00
10.01.24
52.62%
11.01.23

Could be very worthwhile Investment >20% year
Intercept Pharmaceuticals

Start price
Target price
Perf. (%)
€13.26
09.01.22
-
09.01.23
7.05%
10.01.23

Risky Investment
buy
Immunogen Inc.

Start price
Target price
Perf. (%)
€4.33
24.12.22
€7.00
31.12.25
-8.10%
09.01.23

Could be very worthwhile Investment >20% year
buy
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€3.68
04.01.23
€5.00
31.12.25
25.54%
09.01.23

Could be very worthwhile Investment >20% year
buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€1.27
03.01.23
-
03.01.24
-5.60%
08.01.23

Could be worthwhile Investment >10% per year
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€9.33
27.12.22
-
27.12.23
-57.45%
06.01.23

Could be very worthwhile Investment >20% year
buy
Cytomx Therapeutics Inc

Start price
Target price
Perf. (%)
€1.73
05.01.23
€3.00
31.12.25
37.80%
06.01.23

Could be very worthwhile Investment >20% year
buy
Geron Corp.

Start price
Target price
Perf. (%)
€2.50
04.01.23
€6.00
31.12.25
38.38%
04.01.23

Could be very worthwhile Investment >20% year
Intercept Pharmaceuticals

Start price
Target price
Perf. (%)
€13.70
30.09.22
€9.00
31.01.23
-12.08%
03.01.23

Could be very worthwhile Investment >20% year
buy
Meta Material Inc.

Start price
Target price
Perf. (%)
€1.03
26.12.22
-
03.03.23
9.95%
02.01.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€32.60
28.12.22
€40.00
28.12.23
50.15%
02.01.23

buy
Onto Innovation Inc.

Start price
Target price
Perf. (%)
€89.00
30.12.21
€96.00
30.12.22
-28.09%
30.12.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Future proof or reliable business model
buy
TG Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.32
21.12.22
€11.00
31.03.24
29.21%
28.12.22

Could be very worthwhile Investment >20% year
buy
Sorrento Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.97
27.12.21
€6.00
27.12.22
-83.85%
28.12.22

Could be worthwhile Investment >10% per year
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€4.77
12.12.22
-
12.12.23
-33.89%
27.12.22

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
buy
Microstrateg.a New

Start price
Target price
Perf. (%)
€184.72
12.12.22
€380.00
12.12.23
-24.00%
26.12.22

Could be very worthwhile Investment >20% year
buy
Powell Industries Inc.

Start price
Target price
Perf. (%)
€33.80
11.12.22
€37.00
11.12.23
-1.18%
22.12.22

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
High dividend yield expected
buy
ADTRAN Holdings Inc.

Start price
Target price
Perf. (%)
€19.95
21.11.22
-
21.12.22
-10.53%
22.12.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
buy
ADTRAN Holdings Inc.

Start price
Target price
Perf. (%)
€19.95
21.11.22
-
21.12.22
-10.53%
22.12.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€20.67
26.10.22
€35.00
31.12.24
-41.33%
21.12.22

Could be very worthwhile Investment >20% year
buy
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€5.98
28.11.22
-
28.11.23
-20.32%
12.12.22

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
buy
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€5.98
28.11.22
-
28.11.23
-20.32%
10.12.22

Risky Investment